# Banner Health

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/banner-health/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 97.3 |
| Citations | 114,905 |
| City | Phoenix |
| Country | US |
| Description | Banner Health is a research organisation in Phoenix, US. OpenAlex records 2,615 works and 114,905 citations for it. 956 researchers list it as their most recent affiliation. |
| Homepage | https://www.bannerhealth.com/ |
| OpenAlex ID | https://openalex.org/I2802412784 |
| Researchers | 956 |
| ROR ID | https://ror.org/039wwwz66 |
| Type | healthcare |
| Wikidata ID | https://www.wikidata.org/wiki/Q4856918 |
| Works | 2,615 |

## University papers

Showing 12 of 18.

- [Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup](https://scholariq.org/papers/revised-criteria-for-diagnosis-and-staging-of-alzheimer-s-disease-alzheimer-s/)
- [Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature](https://scholariq.org/papers/correlation-of-alzheimer-disease-neuropathologic-changes-with-cognitive-status-a/)
- [Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders](https://scholariq.org/papers/discriminative-accuracy-of-plasma-phospho-tau217-for-alzheimer-disease-vs-other/)
- [Clinical Practice Guideline (Update): Adult Sinusitis](https://scholariq.org/papers/clinical-practice-guideline-update-adult-sinusitis/)
- [International consensus statement on allergy and rhinology: rhinosinusitis 2021](https://scholariq.org/papers/international-consensus-statement-on-allergy-and-rhinology-rhinosinusitis-2021/)
- [International Consensus Statement on Allergy and Rhinology: Rhinosinusitis](https://scholariq.org/papers/international-consensus-statement-on-allergy-and-rhinology-rhinosinusitis/)
- [<i>PGC-1</i> α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease](https://scholariq.org/papers/i-pgc-1-i-a-potential-therapeutic-target-for-early-intervention-in-parkinson-s/)
- [Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2](https://scholariq.org/papers/pharmacological-treatment-of-coronary-artery-disease-with-recombinant-fibroblast/)
- [International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis](https://scholariq.org/papers/international-consensus-statement-on-allergy-and-rhinology-allergic-rhinitis-2/)
- [International consensus statement on allergy and rhinology: Allergic rhinitis – 2023](https://scholariq.org/papers/international-consensus-statement-on-allergy-and-rhinology-allergic-rhinitis-3/)
- [Clinical Trials in Coronary Angiogenesis: Issues, Problems, Consensus](https://scholariq.org/papers/clinical-trials-in-coronary-angiogenesis-issues-problems-consensus/)
- [Local Perivascular Delivery of Basic Fibroblast Growth Factor in Patients Undergoing Coronary Bypass Surgery](https://scholariq.org/papers/local-perivascular-delivery-of-basic-fibroblast-growth-factor-in-patients/)

## University top topics

Showing 8 of 25.

- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)
- [Shoulder Injury and Treatment](https://scholariq.org/topics/shoulder-injury-and-treatment/)
- [Neuroinflammation and Neurodegeneration Mechanisms](https://scholariq.org/topics/neuroinflammation-and-neurodegeneration-mechanisms/)
- [Mechanical Circulatory Support Devices](https://scholariq.org/topics/mechanical-circulatory-support-devices/)
- [Cholinesterase and Neurodegenerative Diseases](https://scholariq.org/topics/cholinesterase-and-neurodegenerative-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.